ADMA Biologics(ADMA)

Search documents
5 Stocks With Recent Price Strength With More Upside Left
Zacks Investment Research· 2024-03-21 13:40
U.S. stock markets have been maintaining their northbound journey in the first quarter of 2024 after an impressive 2023. Year to date, the three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — have rallied 4.8%, 10.2% and 10.9%, respectively.On Mar 20, after its FOMC meeting, the Fed kept the benchmark lending rate constant in the range of 5.25-5.5%. However, the Fed’s latest “dot-plot” (a closely watched matrix of anonymous projections from the 19 officials who comprise the FOMC) show ...
Recent Price Trend in ADMA Biologics (ADMA) is Your Friend, Here's Why
Zacks Investment Research· 2024-03-20 13:50
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done.The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the st ...
Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 33.56%: Read This Before Placing a Bet
Zacks Investment Research· 2024-03-18 14:56
Adma Biologics (ADMA) closed the last trading session at $5.99, gaining 13.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8 indicates a 33.6% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $1.63. While the lowest estimate of $6 indicates a 0.2% increase from the current price level, the most optimistic analyst expects th ...
Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest?
Zacks Investment Research· 2024-03-18 14:31
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Let's take a look at what these Wall Street heavyweights have to say about Adma Biologics (ADMA) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Adma Biologics currently has an aver ...
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
Newsfilter· 2024-03-11 11:00
FDA Approval Provides for Room Temperature (25°C) Storage Conditions for up to 4 Weeks at Any Point During the 36-Month Approved Shelf Life Extends the Prior Room Temperature Storage Allowance for the Full 36-months for ASCENIV and BIVIGAM Provides for Improved Inventory Management and Ease of Product Administration to Patients Approval of Extended Ambient Storage Conditions for ASCENIV & BIVIGAM is Immediately Effective and Now Commercially Available to U.S. Healthcare Providers RAMSEY, N.J. and BOCA RATON ...
Finding Cheap Stocks Under $10 to Buy in March
Zacks Investment Research· 2024-03-05 19:50
The Nasdaq and the S&P 500 fell on Tuesday morning. The selling appeared unavoidable after the Nasdaq hit new highs late last week for the first time since the final months of 2021. The bulls remain firmly in control and comparisons to the Dot-com bubble don’t seem to hold up to scrutiny.There could be more near-term selling to wipe away the excess foam off the top of the market. Investors should watch how the Nasdaq interacts with its 21-day and 50-day moving averages in the coming days and weeks since Wal ...
Adma Biologics (ADMA) Is Up 4.94% in One Week: What You Should Know
Zacks Investment Research· 2024-03-05 18:01
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even ...
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
Newsfilter· 2024-03-05 12:00
RAMSEY, N.J. and BOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) ("ADMA" or the "Company"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced Adam Grossman, President and Chief Executive Officer, will participate in a fireside chat at the Raymond James Institutional Investor Conference on March 6, 2024, at 11:35 a.m. ET. A live audio webcast of the call will be available under ...
Adma Biologics (ADMA) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks Investment Research· 2024-03-04 14:51
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done.Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate rev ...
4 Stocks With Increasing Cash Flows to Enrich Your Portfolio
Zacks Investment Research· 2024-03-04 13:06
If achieving profit is a company’s goal, then having a healthy cash flow is essential to its existence, development and success. This is because cash offers strength, vitality and flexibility to make investment decisions as well as the fuel to run the growth engine.Investors flock to companies that earn profits but even a profitable business can succumb to failure if its cash flow is irregular and eventually files for bankruptcy. But a company’s resiliency can be fairly judged when its efficacy in generatin ...